Biosimilars and implications for pharmacy practice: Ready or not, here they come!

Pharmacy Practice

  • Andrea L. Hobbs1PharmD, Transitions of Care Clinical Specialist and Pharmacy Residency Coordinator, Bon Secours Memorial Regional Medical Center, Mechanicsville, VA, United States.
  • Joshua P. Crawford2PharmD, BCPS, System Director Clinical Pharmacy Services, Bon Secours Mercy Health, Cincinnati, OH, United States.

Volume 17 Issue 3 Pages 1-5

DOI: 10.18549/PharmPract.2019.3.1659

Keywords

  • Biosimilar Pharmaceuticals
  • Biological Therapy
  • Therapeutic Equivalency
  • Pharmacists
  • Pharmacovigilance
  • Managed Care Programs
  • United States
Pharmacy Practice

Loading…